In this regard, it is important to note that CD19, a key marker in B-cell differentiation, is aberrantly expressed in leukemic blasts in about 8% of AML cases, but its expression is notably higher in AML with t(8;21), where it is found in 50–93% [62,82]. Here, CD19 is linked to acute myeloid leukemia.